Jeremy Wyatt
ActiGraph, United States CEO
Pensacola, FL
Jeremy Wyatt is the CEO of ActiGraph, a leading provider of motion-sensing wearable technology solutions for pharmaceutical and academic research. With two decades of embedded hardware systems development and related cloud technology expertise, Jeremy has a uniquely well-rounded perspective on the challenges and opportunities of deploying wearable technologies to capture accurate and meaningful data. He is a thought leader in the clinical biosensor space and frequent contributor at clinical drug development events, scientific consortiums, and regulatory meetings. Jeremy is a member and contributor to the Digital Medicine (DiMe) Society and participates in digital biomarker efforts with the Clinical Trial Transformation Initiative (CTTI).